Suppliers / Akron Biotechnology

Akron Biotechnology

United States Updated 9 July 2026

Akron Biotechnology is an API manufacturer based in United States. It holds 3 active US drug master files across a filed portfolio of 3 molecules.

3
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Aldesleukin US FDA 1
Efineptakin Alfa US FDA 1
Heparin Sodium US FDA 1

Also appears on these molecule pages

Heparin API

Questions about Akron Biotechnology

Does Akron Biotechnology hold a US DMF or a CEP?
Akron Biotechnology holds 3 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Akron Biotechnology make?
3 molecules are on record against Akron Biotechnology, including Aldesleukin, Efineptakin Alfa and Heparin Sodium. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Akron Biotechnology comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Gland Pharma shares 1 molecule Sandoz shares 1 molecule Leo Pharma shares 1 molecule Dongying Tiandong Pharmaceutical shares 1 molecule Hebei Changshan Biochemical Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability